Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France: A Self-Controlled Case Series.
Xavier MoissetEmmanuelle LerayChouki ChenafFrederic TaitheBertrand AudoinAurelien MulliezPierre ClavelouPublished in: Neurology (2024)
This study provides Class III evidence that COVID-19 vaccination does not increase the risk of severe relapse in patients with MS.